Status
Conditions
Treatments
About
The purpose of this study is to evaluate the efficacy and safety of irinotecan liposome injection in combined with oxaliplatin plus tegafur (NASOX) for postoperative adjuvant chemotherapy for pancreatic cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
53 participants in 1 patient group
Loading...
Central trial contact
KuiRong Jiang, archiater
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal